NetWorth
LeaderPortfolio
Xianding
Weng Xianding
Rank #2920
CHINA•Healthcare•Medical devices

Weng Xianding

Net Worth
$1.268B
+0.77% (24h)
Weng Xianding, a 64-year-old Chinese entrepreneur, is a prominent figure in the healthcare industry, primarily due to his majority ownership of Shenzhen New Industries Biomedical Engineering, a leading medical device supplier. Weng's entrepreneurial journey includes being the first representative of China's securities watchdog in Shenzhen in 1992. His company, founded in 1995, has become a significant player in the medical device sector. As of March 2026, Weng Xianding's net worth is estimated at $1.4 billion, reflecting his success in the healthcare market and his strategic role as a shareholder. Weng's career showcases a successful path from regulatory roles to entrepreneurship and investment in medical technology, demonstrating the intersection of regulatory insights and business acumen.

How to read Weng Xianding's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Weng Xianding, we anchor the narrative to Medical devices and Medical devices, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $1.268B alongside global rank #2920, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (CHINA) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life

Information on Weng Xianding's early life is limited. However, his career trajectory suggests a strong interest in business and regulatory frameworks. He began his career in the early 1990s.

Rise to Success

Weng Xianding's breakthrough came with his appointment as the first representative of China's securities watchdog in Shenzhen in 1992. This pivotal role gave him insights into the workings of the financial system and the emerging market for medical technologies. He founded Shenzhen New Industries Biomedical Engineering in 1995. Weng's strategic approach and understanding of market dynamics have been key factors in his wealth accumulation and standing on the Forbes Billionaires list.

Key Business Strategies

Weng Xianding's success is rooted in his strategic vision and understanding of the medical device industry. Through Shenzhen New Industries Biomedical Engineering, Weng has focused on providing clinical instruments, playing a crucial role in China's healthcare infrastructure. Weng's majority stake in the company highlights his hands-on approach and investment in the healthcare sector. His business strategies also include expanding the product offerings and establishing a strong market presence.

Philanthropy

Specific details regarding Weng Xianding's philanthropic activities are not readily available in the search results. Further research is needed to determine the scope and nature of his charitable contributions.

Career Timeline

1995

Founded Shenzhen New Industries Biomedical Engineering

Established a company specializing in clinical instruments.

1992

Representative of China's securities watchdog

Appointed as the first representative of China's securities watchdog in Shenzhen.

Philanthropic Impact

UnknownUndisclosed

Unknown

Details not found.

Key Business Ventures & Holdings

CompanyStakeValue
Shenzhen New Industries Biomedical Engineering33.81%—

Net Worth History

In-Depth Analysis

Early Life

Information on Weng Xianding's early life is limited. However, his career trajectory suggests a strong interest in business and regulatory frameworks. He began his career in the early 1990s.

Rise to Success

Weng Xianding's breakthrough came with his appointment as the first representative of China's securities watchdog in Shenzhen in 1992. This pivotal role gave him insights into the workings of the financial system and the emerging market for medical technologies. He founded Shenzhen New Industries Biomedical Engineering in 1995. Weng's strategic approach and understanding of market dynamics have been key factors in his wealth accumulation and standing on the Forbes Billionaires list.

Key Business Strategies

Weng Xianding's success is rooted in his strategic vision and understanding of the medical device industry. Through Shenzhen New Industries Biomedical Engineering, Weng has focused on providing clinical instruments, playing a crucial role in China's healthcare infrastructure. Weng's majority stake in the company highlights his hands-on approach and investment in the healthcare sector. His business strategies also include expanding the product offerings and establishing a strong market presence.

Philanthropy

Specific details regarding Weng Xianding's philanthropic activities are not readily available in the search results. Further research is needed to determine the scope and nature of his charitable contributions.

Data Sources & Methodology

Figures for Weng Xianding are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.

You may also like

HubAll BillionairesHubGlobal RankingsHubNewsroom